| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Manuf, Strategy& Bus Dev. | Chief Financial Officer
1 company
Sean Murphy last filed a Form 4 in June 2025, as Director at TLSI. Sean Murphy's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 123,989 shares of TLSI. Net of sales, the TLSI filings show accumulation of 30,000 shares.
Sean Murphy has 7 Form 4 filings on record from August 2023 to June 2025, all as Director at TriSalus Life Sciences (TLSI), 2023–2025.
The 11 reported transactions were 5 option or other derivative awards, 4 stock awards and 2 open-market purchases.
Counted by filing, the open-market trades come to 1 purchase worth about $157K and no sales.
The only open-market purchase was 30,000 shares of TLSI at an average $5.24 on January 28, 2025, about $157K. Twelve months later TLSI was up 0%.
Shares as reported in the last Form 4 for each company; the most recent is from June 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 28, 2025 | TLSI Trisalus Life Sciences, Inc. | Chief Manuf, Strategy& Bus Dev. | Buy | 30,000 | $5.24 | $157,200.00 | +17.9% | +15.1% | -0.4% |